- $79.37m
- $78.00m
- $0.02m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.009 | 0.007 | 0.015 | 0.036 | 0.019 |
Cost of Revenue | |||||
Gross Profit | 0.003 | 0.001 | 0.003 | 0.008 | -0.006 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.36 | 0.68 | 2.52 | 2.51 | 2.96 |
Operating Profit | -1.35 | -0.673 | -2.5 | -2.47 | -2.94 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.61 | -0.957 | -2.53 | -2.47 | -2.89 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.61 | -0.957 | -2.53 | -2.47 | -2.89 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.61 | -0.957 | -2.53 | -2.47 | -2.89 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.61 | -0.957 | -2.53 | -2.47 | -2.89 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.009 | -0.004 | -0.008 | -0.007 | -0.007 |